Article
Cbl-b promotes chemotherapy-induced apoptosis in rat basophilic leukemia cells by suppressing PI3K/Akt activation and enhancing MEK/ERK activation.
Molecular and cellular biochemistry - 1 Jul 2010
Qu Xiujuan, Li Yingchun, Liu Jing, Xu Ling, Zhang Ye, Hu Xuejun, Hou Kezuo, Liu Yunpeng
Abstract excerpt
The ubiquitin ligase Cbl-b is a negative regulator of the PI3K/Akt pathway, the survival pathway implicated in chemotherapy resistance. However, it remains unclear whether Cbl-b can regulate chemosensitivity through modulating Akt activation. In this study, VP-16-induced RBL-2H3 cells apoptosis was accompanied by the activation of Akt and ERK. The PI3K inhibitor LY294002, not the ERK inhibitor PD98059, enhanced...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
